nanovibronix.com (NAOV): שווי שוק להכנסות

NanoVibronix, Inc. (NAOV) develops patent-protected devices to combat catheter-associated infections, ensuring high profitability. The price-to-sales trend on the GURU.Markets chart confirms this trajectory, with the metric recorded at 1.60. The company is implementing ultrasound therapy for drug-free wound healing, leveraging a streamlined internal warehouse system to ensure stable supplies to clinics.
פילוחים אנליטיים של חברת NanoVibronix, Inc. (NAOV)

Investors utilize this ratio as an indicator of market confidence in the company's future expansion rates. The ratio of market capitalization to annual revenue in the price/sales multiple allows for an assessment of the asset's premium, which is critical for NanoVibronix, Inc. (NAOV) due to the risks of slow acoustic technology adoption and reliance on insurance reimbursement systems amid limited marketing.